市场调查报告书
商品编码
1466359
医用塑胶市场:按类型、应用分类 - 2024-2030 年全球预测Medical Plastics Market by Type (Biodegradable Polymers, Engineering Plastics, High-performance Plastics), Application (Drug Delivery, Medical Disposables, Medical Instruments & Tools) - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年医用塑胶市场规模为332.5亿美元,预计2024年将达363.3亿美元,2030年将达627.1亿美元,复合年增长率为9.48%。
医用塑胶市场具体包括用于医疗应用的塑胶材料的生产和销售。这包括用于医疗设备、包装、植入和各种医疗保健产品的塑胶。塑胶重量轻、弹性且可消毒,这使得它们在医疗领域至关重要。此市场范围延伸至医用级塑胶材料的生产和各个医疗保健领域的最终用途,包括医院、诊所和家庭护理场所。医用塑胶市场受到多种成长要素的影响,例如医疗设备的技术进步、医疗保健产业的扩张、对病人安全的日益关注以及维持无菌环境的需要。此外,新医疗设备的监管核准和新兴市场的存在正在支持医用塑胶产业的扩张。然而,塑胶对环境的影响和医疗废弃物管理的压力已成为重大挑战。此外,先进的医用塑胶材料价格昂贵,可能难以广泛采用,特别是在成本敏感的市场。最新进展包括生物基和生物分解性塑胶的开发、用于植入设备的先进聚合物的设计以及自订医疗部件采用 3D 列印技术。此外,对医疗基础设施和技术创新的投资增加正在开闢新的应用和产品开发的可能性。
主要市场统计 | |
---|---|
基准年[2023] | 332.5亿美元 |
预测年份 [2024] | 363.3亿美元 |
预测年份 [2030] | 627.1亿美元 |
复合年增长率(%) | 9.48% |
类型:对医用塑胶废弃物日益增长的环境担忧导致更多地采用生物分解性塑胶
可生物分解性聚合物受到医疗产业的青睐,因为它们在使用后会自然降解,减少对环境的影响和医疗废弃物。这些聚合物通常用于药物传输系统、缝合线、组织工程等。工程塑胶的选择取决于其机械强度、耐化学性和热稳定性。应用包括医疗外壳、连接器和耐用设备零件。高性能塑胶因其耐热性、强度和耐化学性而被选用于重要的医疗应用。用于手术器械、医疗植入、高温灭菌托盘等。聚合物共混物结合了不同塑胶的有益特性,提供自订解决方案,例如增强的抗衝击性和弹性。这些是针对特定医疗产品量身定制的,例如软管或矫正器具垫。硅胶因其在较宽温度范围内的生物相容性、弹性和稳定性而成为首选。对于矫正器具、导管和疤痕治疗解决方案至关重要。聚乙烯和聚丙烯等标准塑胶因其成本效益和适应性而被广泛使用。它用于多种应用,包括包装、一次性用品和液体容器。合成橡胶由于具有弹性和弹性,用于医用手套、密封件、垫圈等。提供优异的屏障保护,适合多种应用。
扩大一次性医疗抛弃式的用途,重点是感染疾病预防和大规模生产
医用塑胶在药物输送系统中发挥重要作用,从预填充式注射器到吸入器再到经皮贴片。这种应用的需求是由对安全、无菌和柔性包装的需求所驱动的,这些包装可以保持药物功效以及控制释放能力。医疗抛弃式包括手套、罩衣、口罩、管子和导管等多种产品,由于感染预防意识的增强,需求不断增加。对精度、无菌性和耐用性的要求推动了塑胶在医疗器材和设备中的使用。此类别包括手术器械、诊断设备、治疗设备等。医疗托盘、无菌托盘和实验室器具对于整理、运输和消毒医疗设备和样本至关重要。主要需要的是能够承受严酷的灭菌过程和化学物质并且不会劣化的材料。在义肢和矫正器具领域,医用塑胶因其重量轻、能够适应自订贴合要求以及能够模仿人体四肢的机械特性而备受推崇。
区域洞察
在美洲,复杂的医疗保健系统和严格的 FDA 法规(特别是在美国和加拿大)正在推动该地区主要企业对高品质特殊医疗塑胶的需求。目前,该地区的企业也正在研发引入生物基医用塑料,以回应产业的环保意识。由于医疗保健产业的扩张和医疗设备製造投资的增加,以中国和印度为中心的亚太地区正在经历快速成长。该地区是医用塑胶生产原料的主要来源地,也是医用塑胶及抛弃式出口的核心地区。欧洲、中东和非洲地区呈现出温和的成长模式,欧洲医疗保健产业已成熟,中东和非洲地区的潜力不断增长。该地区是跨国公司和当地企业的所在地,这些公司遵守严格的欧盟法规并专注于创新和永续性。
FPNV定位矩阵
FPNV定位矩阵对于评估医用塑胶市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对医用塑胶市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4. 竞争评估和情报:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1.医用塑胶市场规模及预测如何?
2.医用塑胶市场预测期内需要考虑投资的产品、细分市场、应用和领域有哪些?
3.医用塑胶市场的技术趋势和法规结构是什么?
4.医用塑胶市场主要厂商的市场占有率是多少?
5.进入医用塑胶市场的合适型态和策略手段是什么?
[191 Pages Report] The Medical Plastics Market size was estimated at USD 33.25 billion in 2023 and expected to reach USD 36.33 billion in 2024, at a CAGR 9.48% to reach USD 62.71 billion by 2030.
The medical plastics market encompasses producing and selling plastic materials used specifically for medical applications. This includes plastic in medical devices, packaging, implants, and various healthcare products. Due to their lightweight nature, flexibility, and the ability to be sterilized, plastics have become critical in the medical field. This market's scope extends to the production of medical-grade plastic materials and their end-use across various healthcare sectors, including hospitals, clinics, and home care settings. The medical plastics market is influenced by multiple growth factors, including technological advancements in medical devices, the expanding healthcare sector, increasing focus on patient safety, and the necessity of maintaining sterile environments. Additionally, regulatory approvals for new medical devices and emerging markets in developing nations are driving the expansion of the medical plastics industry. However, the environmental impact of plastics and the stress of medical waste management poses significant challenges. Moreover, the high cost of advanced medical plastic materials can be prohibitive for widespread adoption, particularly in cost-sensitive markets. Recent advancements include the development of bio-based and biodegradable plastics, the design of advanced polymers for implantable devices, and adopting 3D printing technologies for custom medical components. Furthermore, the increased investment in healthcare infrastructure and innovation offers potential for new applications and product development.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 33.25 billion |
Estimated Year [2024] | USD 36.33 billion |
Forecast Year [2030] | USD 62.71 billion |
CAGR (%) | 9.48% |
Type: Emerging adoption of biodegradable plastics owing to rising environmental issues of medical plastic waste
Biodegradable polymers are favored in the medical industry for their ability to decompose naturally after use, reducing environmental impact and medical waste. These polymers are commonly used in drug delivery systems, sutures, and tissue engineering. Engineering plastics are chosen for their mechanical strength, resistance to chemicals, and thermal stability. Applications include medical housings, connectors, and components for devices requiring durability. High-performance plastics are selected for critical medical applications due to their superior heat resistance, strength, and chemical resistance. They are used in surgical instruments, medical implants, and high-temperature sterilization trays. Polymer blends combine the beneficial properties of different plastics, offering custom solutions such as improved impact resistance or flexibility. They are tailored for specific medical products, such as flexible tubing or cushioning in orthotics. Silicone is preferred for its biocompatibility, flexibility, and stability across a wide temperature range. It is essential in prosthetics, catheters, and scar treatment solutions. Standard plastics such as polyethylene and polypropylene are widely used due to their cost-effectiveness and adaptability. They serve in a variety of applications like packaging, disposable items, and fluid containers. Synthetic rubber, due to its elasticity and resilience, is used in medical gloves, seals, and gaskets. It provides good barrier protection and is suitable for multiple usages.
Application: Expanding use of medical disposables with the focus on infection control and mass production
Medical plastics play a vital role in drug delivery systems, from prefilled syringes to inhalers and transdermal patches. The demand for this application stems from the need for safe, sterile, and flexible packaging that can maintain drug efficacy, along with controlled release features. Medical disposables include a broad range of products, including gloves, gowns, masks, tubing, and catheters, which have seen increased demand due to heightened awareness of infection control. The use of plastics in medical instruments & tools is driven by the requirement for precision, sterilizability, and durability. Items in this category include surgical instruments, diagnostic devices, and therapeutic devices. Medical trays, sterilization trays, & lab wares are essential for the organization, transport, and sterilization of medical equipment and samples. The primary need is for materials that can withstand harsh sterilization processes and chemicals without degrading. In the field of prosthetics, medical plastics are prized for their lightweight nature, adaptability to custom-fit requirements, and ability to mimic the mechanical properties of human limbs.
Regional Insights
In the Americas, the presence of advanced healthcare systems, particularly in the U.S. and Canada, along with rigorous FDA regulations, pivot the demand towards high-quality, specialized medical plastics, with key regional companies. Currently, companies in the region are also conducting R&D on introducing bio-based medical plastics to meet the environmental consciousness of the industry. The APAC region, led by China and India, is experiencing rapid growth due to expanding healthcare sectors and increasing investments in medical devices manufacturing. The region portrays as a major raw material provider for the production of medical plastics and is a core region for export of medical plastics and disposables. The EMEA region shows a moderate growth pattern, with a well-established medical industry in Europe, and rising potentials in the MEA segment. The region's landscape features both global players and local companies that comply with strict EU regulations, focusing on innovation and sustainability in medical plastics production.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Medical Plastics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Medical Plastics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Medical Plastics Market, highlighting leading vendors and their innovative profiles. These include Ansini Limited, Arkema S.A., Avantor, Inc., Avient Corporation, BASF SE, Celanese Corporation, Compagnie de Saint-Gobain S.A., Covestro AG, Dow Inc., DuPont de Nemours, Inc., Eagle Plastics Limited, Eastman Chemical Company, Elos Medtech AB, Ensinger GmbH, Evonik Industries AG, Flamingo Additives & Colourants LLP, Fortune Medical Plastic Products Company, Foster Corporation, Mitsubishi Corporation, Modern Plastics, Inc., Nolato AB, Orthoplastics Ltd. by Viant Medical, Putnam Plastics Corporation, RTP Company, Rochling SE & Co. KG, SABIC, Solvay S.A., Tekni-Plex, Inc., Trelleborg AB, and Trinseo PLC.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Medical Plastics Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Medical Plastics Market?
3. What are the technology trends and regulatory frameworks in the Medical Plastics Market?
4. What is the market share of the leading vendors in the Medical Plastics Market?
5. Which modes and strategic moves are suitable for entering the Medical Plastics Market?